{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MAB"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAB\",,,,,undefined,":{"symbol":"MAB","market":"US","secType":"STK","nameCN":"Eaton Vance Massachusetts Municipal Bond Fund","latestPrice":12.28,"timestamp":1575925200000,"preClose":12.28,"halted":4,"volume":0,"delay":0,"floatShares":0,"shares":1768514,"eps":-0.3939,"marketStatus":"Delisted","change":0,"latestTime":"12-09 16:00:00 EST","open":12.28,"high":12.28,"low":12.28,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.3939,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1743667200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":12.28,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAB\",,,,,undefined,":{"symbol":"MAB","floatShares":0,"roa":"--","roe":"--","lyrEps":-0.3939,"shares":1768514,"dividePrice":0.6396,"high":12.28,"amplitude":0,"preClose":12.28,"low":12.28,"week52Low":11.77,"pbRate":"0.86","week52High":13.97,"institutionHeld":0.0082,"latestPrice":12.28,"eps":-0.3939,"divideRate":0.052085,"volume":0,"delay":0,"ttmEps":-0.3939,"open":12.28},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MAB\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAB\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521072414","title":"Press Release: Soligenix Announces Recent Accomplishments and Year End 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2521072414","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521072414?lang=en_us&edition=fundamental","pubTime":"2025-03-21 19:30","pubTimestamp":1742556600,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., March 21, 2025 /PRNewswire/ -- Soligenix, Inc.  , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and financial results for the year ended December 31, 2024.Dr. Schaber continued, \"With approximately $7.8 million in cash at December 31, 2024, we are committed to disciplined resource allocation to achieve our strategic goals. While this cash balance provides operating runway through 2025, we continue to evaluate all strategic options, including partnership, merger and acquisition, government grants, and potential financing opportunities to advance our late-stage pipeline and the Company.\". with early-stage CTCL. To view this press release, please click here.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4604","MAB","TM","SNGX","BK4099","BK4555","BK4139","BK4585","BK4168","03160","IDR","R","BK4022","BK4588"],"gpt_icon":0},{"id":"2501235665","title":"BRIEF-I-MAB Announces Portfolio Prioritization Of Givastomig As Lead Clinical Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2501235665","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501235665?lang=en_us&edition=fundamental","pubTime":"2025-01-06 20:29","pubTimestamp":1736166540,"startTime":"0","endTime":"0","summary":"Jan 6  - I-Mab   :   * I-MAB ANNOUNCES PORTFOLIO PRIORITIZATION OF GIVASTOMIG  AS LEAD CLINICAL PROGRAM   * I-MAB - CASH BALANCE OF $184.4 MILLION AS OF SEPT 2024, EXPECTED TO SUPPORT OPERATIONS INTO 2027Source text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMAB","BK4505","BK4526","MAB","BK4535","BK4139"],"gpt_icon":0},{"id":"2481175551","title":"Mitchells & Butlers (MAB) was downgraded to a Hold Rating at Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2481175551","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481175551?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:49","pubTimestamp":1731066598,"startTime":"0","endTime":"0","summary":"Deutsche Bank analyst Tim Barrett downgraded Mitchells & Butlers (MAB – Research Report) to a Hold today and set a price target of p280.00. The com...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mitchells-butlers-mab-was-downgraded-to-a-hold-rating-at-deutsche-bank?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mitchells-butlers-mab-was-downgraded-to-a-hold-rating-at-deutsche-bank?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DB","MAB"],"gpt_icon":0},{"id":"2472958232","title":"MAB Director’s Share Dealings Disclosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2472958232","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472958232?lang=en_us&edition=fundamental","pubTime":"2024-10-04 19:22","pubTimestamp":1728040932,"startTime":"0","endTime":"0","summary":"Mortgage Advice Bureau (Holdings) (GB:MAB1) has released an update. Mortgage Advice Bureau (Holdings) PLC has announced that on October 1, 2024, th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mab-directors-share-dealings-disclosed?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mab-directors-share-dealings-disclosed?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAB"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-12-12","symbol":"MAB","amount":0.0533,"name":"Eaton Vance Massachusetts Muni","currency":"USD","type":"dividend","dateTimestamp":1544590800000},{"market":"US","date":"2018-11-21","symbol":"MAB","amount":0.0434,"name":"Eaton Vance Massachusetts Muni","currency":"USD","type":"dividend","dateTimestamp":1542776400000},{"market":"US","date":"2018-10-23","symbol":"MAB","amount":0.0434,"name":"Eaton Vance Massachusetts Muni","currency":"USD","type":"dividend","dateTimestamp":1540267200000},{"market":"US","date":"2018-09-20","symbol":"MAB","amount":0.0434,"name":"Eaton Vance Massachusetts Muni","currency":"USD","type":"dividend","dateTimestamp":1537416000000},{"market":"US","date":"2018-08-23","symbol":"MAB","amount":0.0434,"name":"Eaton Vance Massachusetts Muni","currency":"USD","type":"dividend","dateTimestamp":1534996800000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAB\",market:\"US\",,,undefined,":[{"executeDate":"2017-01-20","recordDate":null,"paymentDate":null,"value":0.0492,"currency":"USD"},{"executeDate":"2017-02-16","recordDate":null,"paymentDate":null,"value":0.0492,"currency":"USD"},{"executeDate":"2017-03-22","recordDate":null,"paymentDate":null,"value":0.0467,"currency":"USD"},{"executeDate":"2017-04-19","recordDate":null,"paymentDate":null,"value":0.0467,"currency":"USD"},{"executeDate":"2017-05-22","recordDate":null,"paymentDate":null,"value":0.0434,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MAB\",market:\"US\",delay:false,,,undefined,":{}}}